Tags

Type your tag names separated by a space and hit enter

COVID-19: the epidemiology and treatment.
Br J Hosp Med (Lond). 2020 Oct 02; 81(10):1-9.BJ

Abstract

After initially emerging in late 2019, coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly to cause a global pandemic. SARS-CoV-2 is a betacoronavirus that is closely related to severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, all of which can cause severe lung injury, respiratory distress and cytokine storm. While mortality rates associated with SARS-CoV-2 are lower than those associated with severe acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus, it is more contagious and spreads more rapidly than these other viruses. This article summarises the epidemiology and potential options for treating COVID-19 to give a foundation for future studies of the diagnosis, treatment and prevention of this deadly disease.

Authors+Show Affiliations

Department of Clinical Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong Province, China.Health Management Center, The Yantai Qishan Hospital, Yantai, Shandong Province, China.Department of Clinical Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong Province, China.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33135928

Citation

Qu, Liujing, et al. "COVID-19: the Epidemiology and Treatment." British Journal of Hospital Medicine (London, England : 2005), vol. 81, no. 10, 2020, pp. 1-9.
Qu L, Li J, Ren H. COVID-19: the epidemiology and treatment. Br J Hosp Med (Lond). 2020;81(10):1-9.
Qu, L., Li, J., & Ren, H. (2020). COVID-19: the epidemiology and treatment. British Journal of Hospital Medicine (London, England : 2005), 81(10), 1-9. https://doi.org/10.12968/hmed.2020.0580
Qu L, Li J, Ren H. COVID-19: the Epidemiology and Treatment. Br J Hosp Med (Lond). 2020 Oct 2;81(10):1-9. PubMed PMID: 33135928.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19: the epidemiology and treatment. AU - Qu,Liujing, AU - Li,Jinchun, AU - Ren,Hao, Y1 - 2020/10/07/ PY - 2020/11/2/entrez PY - 2020/11/3/pubmed PY - 2020/11/11/medline KW - Antivirals KW - COVID-19 KW - Immunomodulators KW - SARS-CoV-2 KW - Vaccines SP - 1 EP - 9 JF - British journal of hospital medicine (London, England : 2005) JO - Br J Hosp Med (Lond) VL - 81 IS - 10 N2 - After initially emerging in late 2019, coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly to cause a global pandemic. SARS-CoV-2 is a betacoronavirus that is closely related to severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, all of which can cause severe lung injury, respiratory distress and cytokine storm. While mortality rates associated with SARS-CoV-2 are lower than those associated with severe acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus, it is more contagious and spreads more rapidly than these other viruses. This article summarises the epidemiology and potential options for treating COVID-19 to give a foundation for future studies of the diagnosis, treatment and prevention of this deadly disease. SN - 1750-8460 UR - https://www.unboundmedicine.com/medline/citation/33135928/COVID_19:_the_epidemiology_and_treatment_ DB - PRIME DP - Unbound Medicine ER -